No connection

Search Results

BGY vs BME

BGY
BlackRock Enhanced International Dividend Trust
BEARISH
Price
$5.97
Market Cap
$554.8M
Sector
Financial Services
AI Confidence
68%
BME
BlackRock Health Sciences Trust
BEARISH
Price
$42.19
Market Cap
$545.3M
Sector
Financial Services
AI Confidence
65%

Valuation

P/E Ratio
BGY
45.92
BME
--
Forward P/E
BGY
--
BME
--
P/B Ratio
BGY
0.95
BME
1.07
P/S Ratio
BGY
37.26
BME
73.0
EV/EBITDA
BGY
--
BME
--

Profitability

Gross Margin
BGY
100.0%
BME
100.0%
Operating Margin
BGY
65.88%
BME
24.48%
Profit Margin
BGY
283.59%
BME
0.0%
ROE
BGY
7.05%
BME
-4.63%
ROA
BGY
0.81%
BME
0.11%

Growth

Revenue Growth
BGY
-12.1%
BME
-2.4%
Earnings Growth
BGY
132.6%
BME
--

Financial Health

Debt/Equity
BGY
--
BME
0.0
Current Ratio
BGY
0.76
BME
0.09
Quick Ratio
BGY
0.73
BME
0.09

Dividends

Dividend Yield
BGY
8.56%
BME
7.43%
Payout Ratio
BGY
366.15%
BME
162.83%

AI Verdict

BGY BEARISH

The Advanced Deterministic Scorecard shows a strong Piotroski F-Score of 7/9, indicating solid financial health, but the absence of an Altman Z-Score limits distress risk assessment. Despite high profitability margins and strong historical price performance, the stock trades at a steep valuation (P/E 45.92 vs. sector avg 31.01) with declining revenue and an unsustainable dividend payout ratio of 366.15%. Technical trend is deeply bearish (10/100), and lack of analyst coverage further increases uncertainty. These factors outweigh the strong F-Score and high yield, leading to a bearish outlook.

Strengths
Strong Piotroski F-Score of 7/9 suggests robust financial health based on earnings quality, leverage, and operating efficiency.
Exceptionally high profitability: 283.59% profit margin and 65.88% operating margin far exceed sector averages.
Attractive dividend yield of 8.56%, above most income-generating peers in financial services.
Risks
Extremely high P/E ratio of 45.92 versus sector average of 31.01, signaling overvaluation relative to earnings.
Unsustainable dividend payout ratio of 366.15%, indicating dividends are not covered by earnings and may be cut.
Revenue declining YoY by -12.10%, conflicting with positive earnings growth and raising quality concerns.
BME BEARISH

The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full bankruptcy risk assessment. Despite a high dividend yield of 7.43%, the unsustainable 162.83% payout ratio raises concerns about dividend continuity. Profitability metrics show mixed signals with a 100% gross margin but zero profit margin and negative ROE of -4.63%, suggesting underlying operational inefficiencies. The technical trend score of 10/100 indicates strong bearish momentum, further weakening the investment case.

Strengths
High dividend yield of 7.43% offers attractive income potential
Zero debt with a Debt/Equity ratio of 0.00 enhances financial flexibility
100% gross margin reflects strong pricing power or low cost of goods sold
Risks
Piotroski F-Score of 5 indicates only moderate financial strength, limiting downside protection
Extremely low current and quick ratios (0.09) signal severe liquidity risk
Unsustainable dividend payout ratio of 162.83% threatens future distributions

Compare Another Pair

BGY vs BME: Head-to-Head Comparison

This page compares BlackRock Enhanced International Dividend Trust (BGY) and BlackRock Health Sciences Trust (BME) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile